PediaNotes

MPS-1 Hurler Disease

3 min read

1. DEFINITION AND CLASSIFICATION

  • Definition: The most severe subtype of Mucopolysaccharidosis Type I (MPS I), a progressive lysosomal storage disorder caused by deficiency of alpha-L-iduronidase.
  • Classification:
    • Hurler (MPS I-H): Severe form with neurodegeneration and early death.
    • Hurler-Scheie (MPS I-H/S): Intermediate form.
    • Scheie (MPS I-S): Mild form with normal intellect and near-normal lifespan.

2. ETIOLOGY AND GENETICS

  • Inheritance: Autosomal Recessive.
  • Gene: IDUA gene on chromosome 4p16.3.
  • Enzyme Defect: Deficiency of alpha-L-iduronidase.
  • Pathophysiology:
    • Failure to degrade glycosaminoglycans (GAGs).
    • Accumulation of Dermatan Sulfate and Heparan Sulfate within lysosomes.
    • Leads to cellular dysfunction, hypertrophy, and multisystem tissue damage.

3. CLINICAL FEATURES

  • General:
    • Inguinal Hernia: often the earliest presenting sign (months before other symptoms).
    • Failure to thrive and short stature (detectable by 2-3 years).
  • Craniofacial:
    • Coarse Facies: Flat nasal bridge, thick lips, macroglossia.
    • Macrocephaly: Scaphocephaly due to premature suture closure.
    • Chronic nasal discharge (“snuffles”).
  • Ophthalmologic:
    • Corneal Clouding: Diffuse, ground-glass opacity (Universal finding).
    • Distinguishes Hurler (Cloudy) from Hunter (Clear).
    • Glaucoma and retinal degeneration.
  • Skeletal (Dysostosis Multiplex):
    • Spine: Thoracolumbar kyphosis (Gibbus deformity) usually at L1-L2; often the first skeletal sign.
    • Hands: Claw-hand deformity, broad digits, proximal pointing of metacarpals.
    • Ribs: Ovoid or paddle-shaped ribs.
    • Joints: Generalized stiffness and contractures.
  • Visceral:
    • Hepatosplenomegaly: Massive, due to GAG storage; abdomen is protuberant.
  • Cardiorespiratory:
    • Valvular heart disease (Mitral/Aortic regurgitation or stenosis).
    • Obstructive sleep apnea due to airway narrowing and macroglossia.
  • Neurologic:
    • Developmental delay (sitting/walking delayed).
    • Progressive intellectual regression after 1-2 years.
    • Communicating hydrocephalus.

4. INVESTIGATIONS

  • Screening Tests:
    • Urine GAGs: Quantitative elevation of dermatan and heparan sulfate.
    • Berry Spot Test: Qualitative screening (toluidine blue).
  • Confirmatory Tests:
    • Enzyme Assay (Gold Standard): Absent alpha-L-iduronidase activity in leukocytes or dried blood spots.
    • Molecular Genetics: IDUA gene sequencing (identifies mutations like W402X).
  • Radiology:
    • Skeletal Survey: Reveals classical Dysostosis Multiplex.
    • Lateral Spine X-ray: Anterior beaking of vertebrae (Gibbus).

5. MANAGEMENT

  • Hematopoietic Stem Cell Transplantation (HSCT):
    • Treatment of Choice for severe Hurler phenotype if diagnosed early (<2 years).
    • Prevents progressive neurocognitive decline.
    • Resolves hepatosplenomegaly and improves hearing/facial features.
    • Does not fully correct skeletal or corneal issues.
  • Enzyme Replacement Therapy (ERT):
    • Agent: Laronidase (recombinant human alpha-L-iduronidase).
    • Role: Manages somatic symptoms (liver, spleen, joints) and improves respiratory function.
    • Limitation: Does not cross the blood-brain barrier; ineffective for CNS disease.
  • Supportive Care:
    • Hernia repair.
    • VP shunt for hydrocephalus.
    • Corneal transplantation for severe clouding.
    • CPAP for sleep apnea.

6. PROGNOSIS

  • Untreated: Progressive deterioration; death usually occurs in the first decade (age 5-10) due to respiratory obstruction or cardiac failure.
  • Treated (Early HSCT): Significantly improved survival and cognitive preservation.

Backlinks

Graph View